North America

Fri
03
May

Using photos of broccoli and weed, Facebook demonstrates how AI will start blocking online sales

The difference between cannabis and tempura broccoli could be the difference between deletion and promotion for weed-minded Facebook users–and artificial intelligence is swooping in for the rescue.

Thu
02
May

We need more research - The last cannabis excuse exposed

The idea that we “need more research” when it comes to cannabis simply isn’t accurate. We have plenty of research on this plant, especially since we’ve been studying it for hundreds, if not thousands of years. Of course, modern medicine requires certain standards when it comes to research, however, even by modern standards we have enough research available to conclude on the safety of cannabis.

The “More Research” fallacy is nothing more than a stall tactic. For thousands of years, humans have been using cannabis for medical, spiritual, and recreational purposes. Throughout all this time, the general consensus is that cannabis is relatively benign and actually very beneficial for humans to consume.

Thu
02
May

CEO of pot producer Cronos talks about Altria deal, weed drinks and the rise of CBD

Cronos Group Inc. is one of two Canadian cannabis producers to have inked a multibillion-dollar deal with a big American company.

Thu
02
May

Oreo says they're 'getting ready' to produce cannabis edibles

Mondelez, maker of Oreos, Chips Ahoy cookies and Maynard candies, say they're preparing to start making marijuana edibles, writes Calvin Hughes.

Mondelez makes a lot of pre-packaged foods that you know and love, and you've probably reached for some of them while in the throes of the munchies. And now Mondelez CEO Dirk Van de Put says they could soon be getting into the marijuana game themselves by introducing some cannabis-infused goodies.

Thu
02
May

Scotts Miracle-Gro jumps most in decade on pot-supplies rebound

Scotts Miracle-Gro Co. (SMG.N) rose the most in a decade after its Roundup herbicide and marijuana-supplies business rebounded from sales slumps, boosting earnings above expectations.

Increased advertising to help counter the negative publicity generated by concerns about Roundup’s safety contributed to a 20 per cent rise in quarterly sales of the weedkiller, Chief Executive Officer Jim Hagedorn said on a conference call with analysts Wednesday to discuss results.

Meanwhile, a burgeoning black market for cannabis in California reversed the effects of a regulatory crackdown last year. Revenue benefited from higher profit margins to illicit growers, said Chris Hagedorn, the CEO’s son and general manager of the pot-supplies business.

Thu
02
May

Curaleaf bets $1.27 billion on cannabis oil in largest U.S. deal

Curaleaf Holdings Inc., the most valuable U.S. marijuana company, is making a big bet on cannabis oil.

The Massachusetts-based company is buying the regulated cannabis business of Cura Partners Inc., a maker of oil for vape pens, in a stock deal valued at about $1.27 billion (US$950 million). That makes it the largest acquisition so far between U.S. cannabis companies. Cura, based in Portland, Oregon, sells its Select brand marijuana products in more than 900 dispensaries, including in California, which is home to the world’s largest legal weed market. It had revenue of about US$117 million last year.

Acquiring Select gives Curaleaf a popular West Coast brand it can sell at its dispensaries around the U.S., according Boris Jordan, the company’s chairman.

Thu
02
May

Marijuana: A $166 billion market?

Marijuana may be "just a plant," but it has Wall Street and investors seeing green and grinning ear to ear at its long-term growth potential.

Long considered a taboo topic, cannabis has forced its way into the mainstream. In the United States, where favorability toward broad-based legalization stood at just 25% in 1995, an all-time record number of people (66%) now want to see marijuana legalized nationally. This growing support is a big reason why there are now 33 states that have given medical cannabis the green light, and 10 of those states have also given the OK to recreational pot.

Thu
02
May

Research begins to develop medical cannabis suppositories for patients suffering from IBD

Panaxia Pharmaceutical Industries Israel and the pharmaceutical company Rafa, announced the signing of a collaboration agreement with PlantEXT Ltd., an Israeli-Canadian medical cannabis company in a recent press release.

Thu
02
May

New funding for cannabis research offers MS patients hope for the future

When Jessica Turner was diagnosed with multiple sclerosis (MS) at age 31, she didn’t want to talk about it—and she didn’t want to take drugs.

“I wasn’t ready to accept that this was happening to me,” Turner tells The GrowthOp. She also didn’t want to accept experiencing the flu-like symptoms that so often accompany interferons, the oldest and most prescribed drug options for patients with relapsing-remitting MS.

Wed
01
May

Cannabis stocks can be a lucrative — but risky — bet

Cannabis stocks aren't just another market fad. They can be a solid long-term bet — as long as you're careful.

Pages

Subscribe to RSS - North America